45,812 Shares in Centene Corporation $CNC Purchased by Commerce Bank

Commerce Bank bought a new position in shares of Centene Corporation (NYSE:CNCFree Report) during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 45,812 shares of the company’s stock, valued at approximately $2,941,000.

Other institutional investors have also modified their holdings of the company. Deutsche Bank AG acquired a new stake in Centene in the second quarter valued at $257,279,000. Hara Capital LLC acquired a new position in shares of Centene during the 2nd quarter worth $5,222,000. Paralel Advisors LLC purchased a new stake in shares of Centene in the 2nd quarter worth about $4,531,000. GSA Capital Partners LLP purchased a new stake in shares of Centene in the 2nd quarter worth about $2,134,000. Finally, Focus Partners Advisor Solutions LLC acquired a new stake in Centene in the 2nd quarter valued at about $4,514,000. Hedge funds and other institutional investors own 93.63% of the company’s stock.

Insider Transactions at Centene

In related news, General Counsel Christopher Koster sold 47,603 shares of the business’s stock in a transaction that occurred on Tuesday, August 18th. The shares were sold at an average price of $65.36, for a total value of $3,111,332.08. Following the completion of the sale, the general counsel directly owned 305,354 shares in the company, valued at approximately $19,957,937.44. The trade was a 13.49% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Insiders own 0.37% of the company’s stock.

Analyst Ratings Changes

A number of equities analysts have issued reports on CNC shares. Weiss Ratings restated a “sell (d)” rating on shares of Centene in a research report on Friday, July 17th. Morgan Stanley set a $66.00 price target on Centene in a research report on Wednesday, July 29th. Wells Fargo & Company set a $69.00 price objective on Centene and gave the company an “equal weight” rating in a research note on Monday, July 13th. Cantor Fitzgerald boosted their price objective on shares of Centene from $60.00 to $75.00 and gave the company an “overweight” rating in a research report on Tuesday, July 7th. Finally, Jefferies Financial Group raised their target price on shares of Centene from $39.00 to $48.00 and gave the stock a “hold” rating in a research report on Wednesday, April 29th. One investment analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating, nine have given a Hold rating and two have given a Sell rating to the company. According to data from MarketBeat, the company has a consensus rating of “Hold” and a consensus price target of $70.05.

Check Out Our Latest Analysis on Centene

Centene Stock Performance

NYSE CNC opened at $65.64 on Tuesday. The business’s 50-day moving average price is $65.00 and its 200 day moving average price is $52.63. The company has a current ratio of 1.15, a quick ratio of 1.15 and a debt-to-equity ratio of 0.71. Centene Corporation has a twelve month low of $28.24 and a twelve month high of $69.36. The company has a market capitalization of $32.43 billion, a PE ratio of -6.29, a price-to-earnings-growth ratio of 0.35 and a beta of 1.08.

Centene (NYSE:CNCGet Free Report) last posted its quarterly earnings results on Monday, July 27th. The company reported $2.51 EPS for the quarter, beating the consensus estimate of $1.09 by $1.42. The company had revenue of $53.58 billion during the quarter, compared to analysts’ expectations of $47.64 billion. Centene had a positive return on equity of 12.12% and a negative net margin of 2.51%.The firm’s revenue was up 9.9% on a year-over-year basis. During the same quarter in the previous year, the business earned ($0.16) EPS. On average, research analysts predict that Centene Corporation will post 4.89 earnings per share for the current year.

Centene Company Profile

(Free Report)

Centene Corporation (NYSE: CNC) is a diversified, multi-national healthcare enterprise that specializes in providing services to government-sponsored and national health programs. The company primarily acts as a managed care organization, delivering healthcare coverage and administering benefits for Medicaid, the Children’s Health Insurance Program (CHIP), Medicare Advantage, and individual marketplace plans. Centene also contracts with federal and state agencies to manage specialty care programs and community-based services for vulnerable populations.

Centene’s offerings extend beyond traditional insurance to include a range of specialty and support services.

Further Reading

Want to see what other hedge funds are holding CNC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Centene Corporation (NYSE:CNCFree Report).

Institutional Ownership by Quarter for Centene (NYSE:CNC)

Receive News & Ratings for Centene Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Centene and related companies with MarketBeat.com's FREE daily email newsletter.